Provided by Tiger Trade Technology Pte. Ltd.

WAVE Life Sciences

7.49
+0.17002.32%
Post-market: 7.500.0100+0.13%19:41 EDT
Volume:5.96M
Turnover:44.63M
Market Cap:1.41B
PE:-6.18
High:7.66
Open:7.45
Low:7.25
Close:7.32
52wk High:21.73
52wk Low:5.02
Shares:188.25M
Float Shares:157.87M
Volume Ratio:1.73
T/O Rate:3.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2118
EPS(LYR):-1.2118
ROE:-54.97%
ROA:-27.18%
PB:2.72
PE(LYR):-6.18

Loading ...

Wave Life Sciences CSO Erik Ingelsson files initial beneficial ownership statement

Reuters
·
13 hours ago

Wave Life Sciences CMO Christopher Wright files initial beneficial ownership statement

Reuters
·
13 hours ago

BRIEF-Wave Life Sciences Announces Proposed Redomiciliation To The United States

Reuters
·
Apr 16

Wave Life Sciences plans US redomiciliation, shifts parent company to Delaware

Reuters
·
Apr 16

Wave Life Sciences Announces Proposed Redomiciliation to the United States

THOMSON REUTERS
·
Apr 16

Wave Life Sciences Ltd - New Delaware Parent Shares to Continue Trading on Nasdaq Under Symbol 'Wve'

THOMSON REUTERS
·
Apr 16

Wave Life Sciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 14

Baozun, Pony AI, Agree Realty, Spruce, Wave Shock

TIPRANKS
·
Apr 04

Gold Royalty, Wave Life Sciences, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
Apr 04

Wave Life Sciences (WVE) Receives a Buy from Wells Fargo

TIPRANKS
·
Apr 01

RA Capital Management reports $56M Wave Life Sciences common share purchase

Reuters
·
Mar 31

Can Wave Life Sciences’ (WVE) Visceral Fat Data Redefine Its Obesity Strategy Despite Modest Weight Loss?

Simply Wall St.
·
Mar 29

Wave Life Sciences' WVE-007 Shows 'Modest' Weight Reduction in Trial, Wedbush Says

MT Newswires Live
·
Mar 27

Wave Life Sciences Is Maintained at Buy by B of A Securities

Dow Jones
·
Mar 27

Wave Life Sciences removed from Best Ideas List at Wedbush

TIPRANKS
·
Mar 27

Wave Life Sciences Ltd : Wedbush Removes Stock From Its Best Ideas List

THOMSON REUTERS
·
Mar 27

Wave Life Sciences Ltd : Wedbush Cuts Target Price to $15 From $35

THOMSON REUTERS
·
Mar 27

Wedbush Cuts Price Target on Wave Life Sciences to $15 From $35, Keeps Outperform Rating

MT Newswires Live
·
Mar 27

Wave Life Sciences Ltd : Raymond James Cuts Target Price to $12 From $26

THOMSON REUTERS
·
Mar 27

NASD Most Active Issues

Dow Jones
·
Mar 27